journal article·2024-04-10Open access

Nanoparticle-Catalyzed Transamination under Tumor Microenvironment Conditions: A Novel Tool to Disrupt the Pool of Amino Acids and GSSG in Cancer Cells

Javier Bonet-Aleta, Juan Vicente Alegre-Requena, Javier Martin-Martin, Miguel Encinas-Gimenez, Ana Martín-Pardillos, Pilar Martin-Duque, Jose L. Hueso, Jesus Santamaria

Nano Letters· Volume 24· Issue 14

Abstract

High Resolution Image Download MS PowerPoint Slide Catalytic cancer therapy targets cancer cells by exploiting the specific characteristics of the tumor microenvironment (TME). TME-based catalytic strategies rely on the use of molecules already present in the TME. Amino groups seem to be a suitable target, given the abundance of proteins and peptides in biological environments. Here we show that catalytic CuFe 2 O 4 nanoparticles are able to foster transaminations with different amino acids and pyruvate, another key molecule present in the TME. We observed a significant in cellulo decrease in glutamine and alanine levels up to 48 h after treatment. In addition, we found that di- and tripeptides also undergo catalytic transamination, thereby extending the range of the effects to other molecules such as glutathione disulfide (GSSG). Mechanistic calculations for GSSG transamination revealed the formation of an imine between the oxo group of pyruvate and the free −NH 2 group of GSSG. Our results highlight transamination as alternative to the existing toolbox of catalytic therapies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanocluster Synthesis and Applications · Epigenetics and DNA Methylation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Instituto de Nanociencia y Materiales de Aragon (INMA) CSIC-Universidad de Zaragoza, Campus Rio Ebro, Edificio I+D, C/Poeta Mariano Esquillor, s/n, 50018 Zaragoza, Spain

Department of Chemical and Environmental Engineering, University of Zaragoza, Campus Rio Ebro, C/María de Luna, 3, 50018 Zaragoza, Spain

Networking Res. Center in Biomaterials, Bioengineering and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain

Instituto de Investigación Sanitaria (IIS) de Aragón, Avenida San Juan Bosco, 13, 50009 Zaragoza, Spain

Departamento de Química Inorgánica, Instituto de Síntesis Química y Catálisis Homogénea (ISQCH), CSIC-Universidad de Zaragoza, C/Pedro Cerbuna 12, 50009 Zaragoza, Spain

Department of Organic Chemistry, University of Zaragoza, 50009 Zaragoza Spain

Surgery Department, Medicine Medical School, University of Zaragoza, 50009 Zaragoza, Spain

Funding

European Research Council · Agencia Estatal de Investigaci?n · European Social Fund Plus

References (63)

Show source-provided references
1. 10.1002/anie.20221542710.1002/anie.202215427 ↗
2. 10.1002/anie.20170560910.1002/anie.201705609 ↗
3. 10.1002/anie.20160983710.1002/anie.201609837 ↗
4. 10.1038/s41565-021-00910-710.1038/s41565-021-00910-7 ↗
5. 10.1016/j.trechm.2021.11.00810.1016/j.trechm.2021.11.008 ↗
6. 10.1021/acsnano.9b0045710.1021/acsnano.9b00457 ↗
7. 10.1002/adma.20190177810.1002/adma.201901778 ↗
8. 10.31635/ccschem.020.20200051910.31635/ccschem.020.202000519 ↗
9. 10.1039/D0CS00718H10.1039/D0CS00718H ↗
10. 10.1021/acs.chemrev.8b0062610.1021/acs.chemrev.8b00626 ↗
11. 10.1021/acs.chemrev.0c0097710.1021/acs.chemrev.0c00977 ↗
12. Szatrowski T. P. · Cancer Res. · 1991 · 51 · 794
13. 10.1002/adtp.20200011010.1002/adtp.202000110 ↗
14. 10.1016/j.ccell.2020.06.00110.1016/j.ccell.2020.06.001 ↗
15. 10.1016/j.tibs.2015.12.00110.1016/j.tibs.2015.12.001 ↗
16. 10.1126/sciadv.abj883310.1126/sciadv.abj8833 ↗
17. 10.1021/acsami.2c1958510.1021/acsami.2c19585 ↗
18. 10.1002/wnan.176610.1002/wnan.1766 ↗
19. 10.1021/jacs.1c0853510.1021/jacs.1c08535 ↗
20. 10.1021/jacs.3c0354210.1021/jacs.3c03542 ↗
21. 10.1039/D2SC01379G10.1039/D2SC01379G ↗
22. 10.1126/science.116080910.1126/science.1160809 ↗
23. 10.1016/j.tem.2021.03.00310.1016/j.tem.2021.03.003 ↗
24. 10.1126/sciadv.160020010.1126/sciadv.1600200 ↗
25. 10.1002/anie.20200886810.1002/anie.202008868 ↗
26. Fagan R. L. · 2010 · 3710.1016/B978-008045382-8.00135-0 ↗
27. 10.1182/blood-2006-02-00368110.1182/blood-2006-02-003681 ↗
28. 10.1038/s41392-022-01229-y10.1038/s41392-022-01229-y ↗
29. 10.1016/j.jcis.2022.03.03610.1016/j.jcis.2022.03.036 ↗
30. 10.1021/tx300209310.1021/tx3002093 ↗
31. 10.1038/s41565-021-00858-810.1038/s41565-021-00858-8 ↗
32. 10.1038/s41586-019-0977-x10.1038/s41586-019-0977-x ↗
33. 10.1038/s12276-020-00504-810.1038/s12276-020-00504-8 ↗
34. 10.1093/jnci/93.4.26610.1093/jnci/93.4.266 ↗
35. 10.1002/chem.20160336610.1002/chem.201603366 ↗
36. 10.1042/bj036030310.1042/bj0360303 ↗
37. 10.1002/anie.20150863510.1002/anie.201508635 ↗
38. 10.1039/C4OB00382A10.1039/C4OB00382A ↗
39. 10.1083/jcb.20180416110.1083/jcb.201804161 ↗
40. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Petersson, G. A.; Nakatsuji, H.; Li, X.; Caricato, M.; Marenich, A. V.; Bloino, J.; Janesko, B. G.; Gomperts, R.; Mennucci, B.; Hratchian, H. P.; Ortiz, J. V.; Izmaylov, A. F.; Sonnenberg, J. L.; Williams; Ding, F.; Lipparini, F.; Egidi, F.; Goings, J.; Peng, B.; Petrone, A.; Henderson, T.; Ranasinghe, D.; Zakrzewski, V. G.; Gao, J.; Rega, N.; Zheng, G.; Liang, W.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Throssell, K.; Montgomery, Jr., J. A.; Peralta, J. E.; Ogliaro, F.; Bearpark, M. J.; Heyd, J. J.; Brothers, E. N.; Kudin, K. N.; Staroverov, V. N.; Keith, T. A.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A. P.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Millam, J. M.; Klene, M.; Adamo, C.; Cammi, R.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Farkas, O.; Foresman, J. B.; Fox, D. J. Gaussian 16, Rev. C.01; Gaussian, Inc.: Wallingford, CT, 2016.
41. 10.1002/wcms.166310.1002/wcms.1663 ↗
42. Landrum, G. RDkit Open-source cheminformatics software. version 2018.03.3.0. 2018, 149 (150), 650. (https://github.com/rdkit/rdkit).
43. 10.1063/1.47500710.1063/1.475007 ↗
44. 10.1039/b810189b10.1039/b810189b ↗
45. 10.1063/1.167752710.1063/1.1677527 ↗
46. 10.1007/BF0053348510.1007/BF00533485 ↗
47. 10.1063/1.43895510.1063/1.438955 ↗
48. 10.1063/1.43898010.1063/1.438980 ↗
49. 10.1063/1.44426710.1063/1.444267 ↗
50. 10.1039/b508541a10.1039/b508541a ↗
51. 10.1039/b515623h10.1039/b515623h ↗
52. 10.1063/1.47465910.1063/1.474659 ↗
53. 10.1021/jp971959k10.1021/jp971959k ↗
54. 10.1063/1.47355810.1063/1.473558 ↗
55. 10.1016/S0166-1280(98)00553-310.1016/S0166-1280(98)00553-3 ↗
56. 10.1063/1.335946910.1063/1.3359469 ↗
57. 10.1021/jp810292n10.1021/jp810292n ↗
58. 10.12688/f1000research.22758.110.12688/f1000research.22758.1 ↗
59. 10.1038/nrc.2016.7110.1038/nrc.2016.71 ↗
60. 10.1038/s43018-023-00649-110.1038/s43018-023-00649-1 ↗
61. 10.1073/pnas.070974710410.1073/pnas.0709747104 ↗
62. Nelson D. L. · 2008
63. 10.1038/ncb327210.1038/ncb3272 ↗